Neurotoxic convulsions induced by histamine H2 receptor antagonists in mice

Toxicology and Applied Pharmacology

Volumn 136, Issue 2, 1996, Pages 317-323

  Shimokawa, Masafumi ^a   Yamamoto, Koujirou ^a   Kawakami, Junichi ^a   Sawada, Yasufumi ^a,b   Iga, Tatsuji ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 7 PHOSPHONOHEPTANOIC ACID; AMINOOXYACETIC ACID; CIMETIDINE; DIAZEPAM; DIZOCILPINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; MUSCIMOL; NIZATIDINE; RANITIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVULSION; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN;

EID: 0030068989     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0038     Document Type: Article

References (48)

1. Amabeoku, G. J., and Chikuni, O. (1993). Cimetidine-induced seizures in mice. Antagonism by some GABAergic agents. Biochem Pharmacol 46, 2171-2175.
2. Baraldi, M., Grandison, L., and Guidotti, A. (1979). Distribution and metabolism of muscimol in the brain and other tissues of the rat. Neuropharmacology 18, 57-62.
3. Black, J. W., and Shankley, N. P. (1985). The isolated stomach preparation of the mouse: a physiological unit for pharmacological analysis. Br. J. Pharmacol. 86, 571-579.
4. 2-receptor antagonists on the mouse isolated stomach assay. Br. J. Pharmacol. 86, 581-587.
5. Callaghan, J. T., Bergstrom, R. F., Obermeyer, B. D., King, E. P., and Offen, W. W. (1985). Intravenous nizatidine kinetics and acid suppression. Clin. Pharmacol. Ther. 37, 162-165.
6. Cantú, T. G., and Korek, J. S. (1991). Central nervous system reactions to histamine-2 receptor blockers. Ann. Intern. Med. 114, 1027-1034.
7. Chapman, A. G., Collins, J. F., Meldrum, B. S., and Westerberg, E. (1983). Uptake of a novel anticonvulsant compound, 2-amino-7-phosphono-[4,5-3H]heptanoic acid, into mouse brain. Neurosci. Lett. 37, 75-80.
8. Croucher, M. J., Collins, J. F., and Meldrum, B. S. (1982). Anticonvulsant action of excitatory amino acid antagonists. Science 216, 899-901.
9. Cunningham, F., Nanavaty, M., Fischer, J., Danziger, L., Rodvold, K., and Bombeck, C. T. (1989). Pharmacokinetic/pharmacodynamic model for nizatidine effect on basal gastric acid output. Clin. Pharmacol. Ther. 45, 141.
10. Czuczwar, S. J., and Meldrum, B. (1982). Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid. Eur. J. Pharmacol. 83, 335-338.
11. Danhof, M., Hisaoka, M., and Levy, G. (1984). Kinetics of drug action in disease states. II. Effect of experimental renal dysfunction on phenobarbital concentrations in rats at onset of loss of righting reflex. J. Pharmacol. Exp. Ther. 230, 627-631.
12. Edmonds, M. E., Ashford, R. F. U., Brenner, M. K., and Saunders, A. (1979). Cimetidine: Does neurotoxicity occur? Report of these cases. J. Roy. Soc. Med. 72, 172-175.
13. Gugler, R., Fuchs, G., Dieckmann, M., and Somogyi, A. A. (1981). Cimetidine plasma concentration-response relationships. Clin. Pharmacol. Ther. 29, 744-748.
14. Haley, T. J., and McCormick, W. G. (1957). Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12, 12-15.
15. Hara, Y., Ally, A., Suzuki, T., and Murayama, S. (1992). Effects of drugs on the convulsion induced by the combination of a new quinolone antimicrobial, enoxacin, and a nonsteroidal anti-inflammatory drug, fenbufen, in mice. Folia Pharmacol. Jpn. 100, 301-305.
16. Holloway, R. H., Kuljian, B., Eshelman, F., and McCallum, R. W. (1984). Effects of ranitidine and of cimetidine on pentagastrin-stimulated gastric acid secretion. Clin. Pharmacol. Ther. 35, 203-207.
17. 2-receptor antagonists. Post Marketing Surveillance 5, 135-144.
18. Kaojarern, S., Feldman, M., Richardson, C. T., and Brater, D. C. (1981). Tiotidine and cimetidine - Kinetics and dynamics. Clin. Pharmacol. Ther. 29, 198-202.
19. 2-receptor antagonists with GABA and benzodiazepine binding sites in the CNS. Eur. J. Pharmacol. 88, 241-245.
20. Lakoski, J. M., Gallager, D. W., and Aghajanian, G. K. (1984). Histamine-induced depression of serotoninergic dorsal raphe neurons: Antagonism by cimetidine, a reevaluation. Eur. J. Pharmacol. 103, 153-156.
21. Lebert, P. A., MacLeod, S. M., Mahon, W. A., Soldin, S. J., and Vandenberghe, H. M. (1981). Ranitidine kinetics and dynamics I: Oral dose studies. Clin. Pharmacol. Ther. 30, 539-544.
22. Lin, J. H., Sugiyama, Y., Awazu, S., and Hanano, M. (1982). In vitro and in vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic models. J. Pharmacokin. Biopharm. 10, 637-647.
23. 2-receptor antagonists. Clin. Pharmacokin. 20, 218-236.
24. Litchfield, J. T., and Wilcoxon, F. (1949). A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96, 99-113.
25. Maggi, A., and Enna, S. J. (1979). Characteristics of muscimol accumulation in mouse brain after systemic administration. Neuropharmacology 18, 361-366.
26. Mignon, M., Chau, N. P., Nguyen-Phuoc, B. K., Sauvage, M., Leguy, F., and Bonfils, S. (1982). Ranitidine upon meal-induced gastric secretion: Oral pharmacokinetics and plasma concentration effect relationships. Br. J. Clin. Pharmacol. 14, 187-193.
27. 2-antagonist, YM-11170 in healthy subjects. Int. J. Clin. Pharmacol. Ther. Toxicol. 22, 214-217.
28. Mogelnicki, S. R., Waller, J. L., and Finlayson, D. C. (1979). Physostigmine reversal of cimetidine-induced mental confusion. J. Am. Med. Assoc. 241, 826-827.
29. Nevins, M. E., and Arnolde, S. M. (1989). A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor. Brain Res. 503, 1-4.
30. Onodera, K., Tuomisto, L., Tacke, U., and Airaksinen, M. (1992). Strain differences in regional brain histamine levels between genetically epilepsy-prone and resistant rats. Meth. Find. Exp. Clin. Pharmacol. 14, 13-16.
31. Peden, N. R., Richards, D. A., Saunders, J. H. B., and Wormsley, K. G. (1979). Pharmacologically effective plasma concentrations of ranitidine. Lancet 2, 199-200.
32. Pounder, R. E., Williams, J. G., Russell, R. C. G., Milton-Thompson, G. J., and Misiewicz, J. J. (1976). Inhibition of food-stimulated gastric acid secretion by cimetidine. Gut 17, 161-168.
33. Ramzan, I. M., and Levy, G. (1986). Kinetics of drug action in disease states. XVIII. Effect of experimental renal failure on the pharmacodynamics of theophylline-induced seizures in rats. J. Pharmacol. Exp. Ther. 240, 584-588.
34. Ramzan, I. M., Yasuhara, M., and Levy, G. (1987). Kinetics of drug action in disease states. XIX. Effect of experimental liver disease on the neurotoxicity of theophylline in rats. J. Pharmacol. Exp. Ther. 241, 236-238.
35. 125I] iodinated probes. Proc. Natl. Acad. Sci. USA 87, 1658-1662.
36. 2-receptor blocking agent, on the central nervous system. J. Yonago. Med. Assoc. 34, 413-431.
37. 2-antagonist, on the central nervous system. Oyo. Yakuri. 25, 107-113.
38. Sawyer, D., Conner, C. S., and Scalley, R. (1981). Cimetidine: Adverse reactions and acute toxicity. Am. J. Hosp. Pharm. 38, 188-197.
39. Shimokawa, M., Yamamoto, K., Kawakami, J., Sawada, Y., and Iga, T. (1994). Effect of renal or hepatic dysfunction on neurotoxic convulsion induced by ranitidine in mice. Pharm. Res. 11, 1520-1524.
40. Slugg, P. H., Haug, M. T., and Pippenger, C. E. (1992). Ranitidine pharmacokinetics and adverse central nervous system reactions. Arch. Intern. Med. 152, 2325-2329.
41. 2 antihistamines. J. Lab. Clin. Med. 97, 112-122.
42. Takagi, K., and Iwasawa, Y. (1968). Intraventricular injection of drugs in the mouse. Yakugaku Zassi 88, 178-184.
43. Tricklebank, M. D., Singh, L., Oles, R. J., Preston, C., and Iversen, S. D. (1989). The behavioral effects of MK-801: A comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167, 127-135.
44. 2 antagonists not caused by GABA blockade. Eur. J. Pharmacol. 124, 231-241.
45. Watanabe, H., Watanabe, K., Goto, Y., and Yamaguchi, M. (1978). Effects of anticonvulsive drugs on convulsions induced by penicillin injected intracerebroventricularly in mice. Yakugaku Zassi 98, 653-659.
46. Yamamoto, K., Naitoh, Y., Inoue, Y., Yoshimura, K., Morikawa, K., Nagata, O., Hashimoto, S., Yamada, T., and Kubo, S. (1988). Seizure discharges induced by the combination of a new quinolinecarboxylic acid antimicrobial drugs and non-steroidal anti-inflammatory drugs - Effect of NY-198 on the central nervous system. Chemotherapy 36, 300-324.
47. Yokoyama, H., Onodera, K., Maeyama, K., Yanai, K., Iinuma, K., Tuomisto, L., and Watanabe, T. (1992). Histamine levels and clonic convulsions of electrically-induced seizure in mice: The effect of alpha-fluoromethylhistidine and metoprine. Naunyn-Schmiedeberg's Arch. Pharmacol. 346, 40-45.
48. 3 receptor antagonist, on electrically induced convulsion in mice. Eur. J. Pharmacol. 234, 129-133.